Sera from patients with seropositive neuromyelitis optica spectral disorders caused the degeneration of rodent optic nerve.

[1]  D. Pham‐Dinh,et al.  The Brown Norway opticospinal model of demyelination: Does it mimic multiple sclerosis or neuromyelitis optica? , 2012, International Journal of Developmental Neuroscience.

[2]  K. Fujihara,et al.  Prognostic factors and disease course in aquaporin-4 antibody-positive patients with neuromyelitis optica spectrum disorder from the United Kingdom and Japan. , 2012, Brain : a journal of neurology.

[3]  A. Verkman,et al.  Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms , 2011, Annals of neurology.

[4]  A. Verkman,et al.  Intravenous Neuromyelitis Optica Autoantibody in Mice Targets Aquaporin-4 in Peripheral Organs and Area Postrema , 2011, PloS one.

[5]  Makoto Nakamura,et al.  Reduced expression of aquaporin-9 in rat optic nerve head and retina following elevated intraocular pressure. , 2010, Investigative ophthalmology & visual science.

[6]  L. Levin,et al.  Superoxide is an associated signal for apoptosis in axonal injury. , 2010, Brain : a journal of neurology.

[7]  J. Honnorat,et al.  Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. , 2010, Brain : a journal of neurology.

[8]  M. Papadopoulos,et al.  Aquaporin-4 in brain and spinal cord oedema , 2010, Neuroscience.

[9]  Brigitte Wildemann,et al.  AQP4 antibodies in neuromyelitis optica: diagnostic and pathogenetic relevance , 2010, Nature Reviews Neurology.

[10]  L. Levin,et al.  Neuroprotection against superoxide anion radical by metallocorroles in cellular and murine models of optic neuropathy , 2010, Journal of neurochemistry.

[11]  M. Papadopoulos,et al.  Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. , 2010, Brain : a journal of neurology.

[12]  B. Hemmer,et al.  Intrathecal pathogenic anti–aquaporin‐4 antibodies in early neuromyelitis optica , 2009, Annals of neurology.

[13]  Y. Itoyama,et al.  Neuromyelitis optica: Pathogenicity of patient immunoglobulin in vivo , 2009, Annals of neurology.

[14]  Y. Blanco,et al.  Cytotoxic effect of neuromyelitis optica antibody (NMO-IgG) to astrocytes: An in vitro study , 2009, Journal of Neuroimmunology.

[15]  S. Sakoda,et al.  Neuromyelitis optica: Passive transfer to rats by human immunoglobulin. , 2009, Biochemical and biophysical research communications.

[16]  T. Yoshiura,et al.  Aquaporin-4 autoimmune syndrome and anti-aquaporin-4 antibody-negative opticospinal multiple sclerosis in Japanese , 2009, Multiple sclerosis.

[17]  K. Fujihara,et al.  Astrocytic necrosis is induced by anti-aquaporin-4 antibody-positive serum , 2009, Neuroreport.

[18]  Makoto Nakamura,et al.  Latanoprost protects rat retinal ganglion cells from apoptosis in vitro and in vivo. , 2009, Experimental eye research.

[19]  C. Lucchinetti,et al.  Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2 , 2008, The Journal of experimental medicine.

[20]  Jacqueline A Palace,et al.  Aquaporin-4 antibodies in neuromyelitis optica and longitudinally extensive transverse myelitis. , 2008, Archives of neurology.

[21]  C. Lucchinetti,et al.  Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica , 2007, Neurology.

[22]  Y. Itoyama,et al.  Anti-aquaporin-4 antibody is involved in the pathogenesis of NMO: a study on antibody titre. , 2007, Brain : a journal of neurology.

[23]  Y. Itoyama,et al.  Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. , 2007, Brain : a journal of neurology.

[24]  Y. Itoyama,et al.  Loss of aquaporin-4 in active perivascular lesions in neuromyelitis optica: a case report. , 2006, The Tohoku journal of experimental medicine.

[25]  T. Nakazawa,et al.  Neuroprotective effect of latanoprost on rat retinal ganglion cells , 2006, Graefe's Archive for Clinical and Experimental Ophthalmology.

[26]  A. Verkman,et al.  The Journal of Experimental Medicine CORRESPONDENCE , 2005 .

[27]  Makoto Nakamura,et al.  Long-term glial reactivity in rat retinas ipsilateral and contralateral to experimental glaucoma. , 2005, Experimental eye research.

[28]  N. Osborne,et al.  Measurement of retinal injury in the rat after optic nerve transection: an RT-PCR study. , 2005, Molecular vision.

[29]  L. Doering,et al.  Ciliary neurotrophic factor protects retinal ganglion cells from axotomy-induced apoptosis via modulation of retinal glia in vivo. , 2005, Journal of neurobiology.

[30]  Ichiro Nakashima,et al.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis , 2004, The Lancet.

[31]  J. Caprioli,et al.  Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model. , 2003, Investigative ophthalmology & visual science.

[32]  A. Weber,et al.  Expression of glial fibrillary acidic protein and glutamine synthetase by Müller cells after optic nerve damage and intravitreal application of brain‐derived neurotrophic factor , 2002, Glia.

[33]  A. Milici,et al.  Early eosinophil infiltration into the optic nerve of mice with experimental allergic encephalomyelitis. , 1998, Laboratory investigation; a journal of technical methods and pathology.

[34]  Nicholas J. Hunt,et al.  Microvascular and Cellular Responses in the Optic Nerve of Rats with Acute Experimental Allergic Encephalomyelitis (EAE) , 1998, Brain pathology.

[35]  P. Agre,et al.  Specialized Membrane Domains for Water Transport in Glial Cells: High-Resolution Immunogold Cytochemistry of Aquaporin-4 in Rat Brain , 1997, The Journal of Neuroscience.

[36]  Robert F. Miller,et al.  Mudpuppy retinal ganglion cell morphology revealed by an hrp impregnation technique which provides golgi‐like staining , 1988, The Journal of comparative neurology.